HOLD NVDA

0 shares at $192.75 on 2026-02-24

Reasoning

HOLD existing 0.9 shares through tomorrow's earnings (Feb 25 after close). Playbook explicitly instructs NOT to add pre-earnings. Current position is 0.9 shares at $184.30 avg cost. Tomorrow's earnings are THE critical event for our semiconductor-heavy portfolio (NVDA, AVGO, TSM, ANET comprise ~65% of holdings). Consensus EPS $1.53, revenue $65.7B. AMD-Meta deal validates AI capex acceleration. Twelve consecutive quarterly beats support upside skew. However, miss risk is material given portfolio concentration. Conservative approach: hold existing position, avoid pre-earnings addition given limited buying power ($70 cash) and binary event risk. Plan post-earnings action after results and Rubin guidance clarity. If beat confirmed with strong guidance, consider $30-40 add on any pullback consolidation. If miss, immediately reassess semiconductor thesis.

Thesis

NVDA post-earnings thesis intact. Stock at $182.49 today (+3%), bought the dip along with MSFT as investors seek cash-rich tech resilient to war impact. GTC 2026 in March is upcoming catalyst. NVDA backed Lumentum with billions for AI infrastructure scaling. Steve Eisman called NVDA's 73% revenue growth 'incredible.' Tom Lee says March is a turnaround month. Multiple analysts maintain $235-300 PTs. Iran conflict creates near-term volatility but doesn't change AI infrastructure demand thesis. Hold 0.9 shares. (long, high confidence)

Cited evidence

Theses